Evidence map›Paper›PMID 24765652›Full record

ArticleJournal of pharmaceutical sciences2014

Direct and real-time quantification of tenofovir release from ph-sensitive microparticles into simulated biological fluids using (1)h nuclear magnetic resonance.

Chi Zhang, Tao Zhang, Nathan A Oyler, Bi-Botti C Youan

Abstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chi Zhang *Department of Chemistry, University of Missouri-Kansas City, Kansas City, Missouri 64110.
Tao Zhang *Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Science, University of Missouri-Kansas City, Kansas City, Missouri 64108.
Nathan A OylerDepartment of Chemistry, University of Missouri-Kansas City, Kansas City, Missouri 64110.
Bi-Botti C YouanLaboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Science, University of Missouri-Kansas City, Kansas City, Missouri 64108.

Funding

Prevention of HIV/AIDS by Stimuli-Sensitive Nanomedicine for Microbicide DeliveryR01AI087304 · NIAID · UNIVERSITY OF MISSOURI KANSAS CITY · PI YOUAN, BI-BOTTI CELESTIN · 2011 to 2014
$1.4M
NIAID NIH HHS R01 AI087304NIAID NIH HHS R01AI087304
6 · The paper itself

Abstract

In vitro drug release evaluation is a very important step toward the quality control of nano- or micro-particular drug delivery systems. However, most quantitative techniques such as high-performance liquid chromatography requires a dialysis membrane to separate the released free drug from these delivery systems, thus are not capable of direct detection and real-time quantification of the drug release kinetics. This study describes, for the first time, a rapid, specific, and direct method for the real-time quantification of in vitro tenofovir (TNF) release from pH-sensitive microparticles using a Varian 400 MHz (1)H nuclear magnetic resonance ((1)H-NMR) spectrometer. Various analytical performance parameters such as linearity, precision, accuracy, limit of quantification, limit of detection, and robustness were validated according to International Conference on Harmonization (ICH) guidelines. The in vitro release of TNF from microparticles in both simulated vaginal fluid (VFS) and the mixture of VFS and simulated semen fluid was monitored and quantified in real time using (1)H-NMR. The capability of real-time quantification of in vitro drug release from microparticles not only provides a more accurate prediction of its biological behavior in vivo, but is also independent of potential interference from the dialysis membrane.

Indexed as

Acquired Immunodeficiency SyndromeAdenineAnti-HIV AgentsDelayed-Action PreparationsFemaleHumansHydrogen-Ion ConcentrationMagnetic Resonance SpectroscopyMaleOrganophosphonatesSemenTenofovirVaginaAdenineAnti-HIV AgentsDelayed-Action PreparationsOrganophosphonatesTenofovir

Identifiers

PMID24765652
PMCPMC4003498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.